Related Experiment Videos
Risk of venous thrombosis with hormone replacement therapy
Lancet (London, England)
|December 14, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The cardiovascular safety of oral alitretinoin: a population-based cohort study involving 19 513 patients exposed to oral alitretinoin.
The British journal of dermatology·2021
Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Clinical pharmacology and therapeutics·2010
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study.
Journal of thrombosis and haemostasis : JTH·2009
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Journal of thrombosis and haemostasis : JTH·2006
[Deep venous thrombosis: epidemiology, acquired risk factors].
Annales de cardiologie et d'angeiologie·2002
Risk of transmission of amyloid β pathology via transfused blood products.
Lancet (London, England)·2026
Cardiac volumes, function, and arterial stiffness five years after severe preeclampsia: A comparison with sedentary and active controls.
Clinical physiology and functional imaging·2026
High-risk pulmonary embolism in the first trimester of pregnancy: Successful thrombolysis with tenecteplase.
Radiology case reports·2026
Rare variant of Zinner syndrome with ectopic seminal vesicle and prostatic hypoplasia: A case report.
Radiology case reports·2026